Literature DB >> 7592779

Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells.

S Grugel1, G Finkenzeller, K Weindel, B Barleon, D Marmé.   

Abstract

Stimulation of NIH 3T3 cells with platelet-derived growth factor (PDGF)-BB and 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances vascular endothelial growth factor (VEGF) gene expression. To address the question of whether Ras and Raf are involved in the induction of VEGF gene expression by PDGF and TPA, we examined the effects of both factors on NIH 3T3 cells stably transfected with v-Ha-ras or v-raf. In serum-starved NIH 3T3 cells, only low levels of mRNA expression can be detected, whereas both ras and raf transformed cell lines express enhanced levels of a 4.3-kilobase VEGF transcript. Stimulation with PDGF or TPA resulted in increased VEGF mRNA in all cell lines, with highest levels found in the transformed cells. Immunofluorescence studies confirmed that the elevated VEGF mRNA expression correlated with enhanced protein levels. Positive immunofluorescence signals could be detected in v-Ha-ras or v-raf transformed cell lines but not in unstimulated NIH 3T3 cells. VEGF from conditioned medium of v-raf transformed NIH 3T3 cells was partially purified by chromatography on heparin-Sepharose. Biological activity of this VEGF protein was demonstrated by competition with binding of recombinant 125I-VEGF165 to human umbilical vein endothelial cells and by its ability to stimulate proliferation of these cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592779     DOI: 10.1074/jbc.270.43.25915

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

2.  Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy.

Authors:  P Vajkoczy; M D Menger; B Vollmar; L Schilling; P Schmiedek; K P Hirth; A Ullrich; T A Fong
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

Review 3.  Establishing a link between oncogenes and tumor angiogenesis.

Authors:  R S Kerbel; A Viloria-Petit; F Okada; J Rak
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

4.  Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways.

Authors:  J L Arbiser; M A Moses; C A Fernandez; N Ghiso; Y Cao; N Klauber; D Frank; M Brownlee; E Flynn; S Parangi; H R Byers; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

Review 5.  Angiogenesis in transgenic models of multistep carcinogenesis.

Authors:  M G D' Angelo; T Afanasieva; A Aguzzi
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

6.  A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors.

Authors:  Elaine T Lam; Cindy L O'Bryant; Michele Basche; Daniel L Gustafson; Natalie Serkova; Anna Baron; Scott N Holden; Janet Dancey; S Gail Eckhardt; Lia Gore
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

7.  The transcription factor Net regulates the angiogenic switch.

Authors:  Hong Zheng; Christine Wasylyk; Abdelkader Ayadi; Joseph Abecassis; Jack A Schalken; Hermann Rogatsch; Nicolas Wernert; Sauveur-Michel Maira; Marie-Christine Multon; Bohdan Wasylyk
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

Review 8.  Treating cancer by inhibiting angiogenesis: new hopes and potential pitfalls.

Authors:  J Rak; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

9.  Molecular and clinical aspects of targeting the VEGF pathway in tumors.

Authors:  Grzegorz Korpanty; Laura A Sullivan; Elizabeth Smyth; Desmond N Carney; Rolf A Brekken
Journal:  J Oncol       Date:  2010-06-10       Impact factor: 4.375

Review 10.  Oncogenes as inducers of tumor angiogenesis.

Authors:  J Rak; J Filmus; G Finkenzeller; S Grugel; D Marmé; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.